Literature DB >> 10867020

Roles of the heparin and low density lipid receptor-related protein-binding sites of protease nexin 1 (PN1) in urokinase-PN1 complex catabolism. The PN1 heparin-binding site mediates complex retention and degradation but not cell surface binding or internalization.

R J Crisp1, D J Knauer, M F Knauer.   

Abstract

We have previously described thrombin (Th)-protease nexin 1 (PN1) inhibitory complex binding to cell surface heparins and subsequent low density lipid receptor-related protein (LRP)-mediated internalization. Our present studies examine the catabolism of urinary plasminogen activator (uPA)-PN1 inhibitory complexes, which, unlike Th.PN1 complexes, bind almost exclusively through the uPA receptor. In addition, the binding site in PN1 required for the LRP-mediated internalization of Th.PN1 complexes is not required for the LRP-mediated internalization of uPA.PN1 complexes. Thus, the protease moiety of the complex partially determines the mechanistic route of entry. Because cell surface heparins are only minimally involved in the binding and internalization of uPA.PN1 complexes, we then predicted that complexes between uPA and the heparin binding-deficient PN1 variant, PN1(K7E), should be catabolized at the same rate as complexes formed with native PN1. Surprisingly, the uPA.PN1(K7E) complexes were degraded at only a fraction of the rate of native complexes. Internalization studies revealed that both uPA. PN1(K7E) and native uPA.PN1 complexes were initially internalized at the same rate, but uPA.PN1(K7E) complexes were rapidly retro-endocytosed in an intact form. By examining the pH dependence of complex binding in the range of 4.0-7.0, it was determined that the uPA.PN1 inhibitory complexes must specifically bind to endosomal heparins at pH 5.5 to be retained and sorted to lysosomes. These studies are the first to document a role for heparins in the catabolism of SERPIN-protease complexes at a point further in the pathway than cell surface binding, and this role may extend to other heparin-binding LRP-internalized ligands.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867020     DOI: 10.1074/jbc.M909172199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1.

Authors:  Danmei Xu; Chad M McKee; Yunhong Cao; Yunchuan Ding; Benedikt M Kessler; Ruth J Muschel
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

2.  Inhibition of PDGF-BB by Factor VII-activating protease (FSAP) is neutralized by protease nexin-1, and the FSAP-inhibitor complexes are internalized via LRP.

Authors:  Lars Muhl; Anders Nykjaer; Malgorzata Wygrecka; Denis Monard; Klaus T Preissner; Sandip M Kanse
Journal:  Biochem J       Date:  2007-06-01       Impact factor: 3.857

3.  Expression pattern of human SERPINE2 in a variety of human tumors.

Authors:  Ying Yang; Xiangke Xin; Xing Fu; Danmei Xu
Journal:  Oncol Lett       Date:  2018-01-18       Impact factor: 2.967

4.  Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma.

Authors:  Chad M McKee; Danmei Xu; Yunhong Cao; Sheheryar Kabraji; Danny Allen; Veerle Kersemans; John Beech; Sean Smart; Freddie Hamdy; Adrian Ishkanian; Jenna Sykes; Melania Pintile; Michael Milosevic; Theodorus van der Kwast; Gaetano Zafarana; Varune Rohan Ramnarine; Igor Jurisica; Chad Mallof; Wan Lam; Robert G Bristow; Ruth J Muschel
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

5.  Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages.

Authors:  Tatiana Smirnova; Laura Bonapace; Gwen MacDonald; Shunya Kondo; Jeffrey Wyckoff; Hilmar Ebersbach; Bérengère Fayard; Arno Doelemeyer; Marie-May Coissieux; Marinus R Heideman; Mohamed Bentires-Alj; Nancy E Hynes
Journal:  Oncotarget       Date:  2016-12-13

Review 6.  Protease Nexin-1 in the Cardiovascular System: Wherefore Art Thou?

Authors:  Celina Madjene; Alexandre Boutigny; Marie-Christine Bouton; Veronique Arocas; Benjamin Richard
Journal:  Front Cardiovasc Med       Date:  2021-03-31

7.  Uptake of Plasmin-PN-1 Complexes in Early Human Atheroma.

Authors:  Kamel Boukais; Richard Bayles; Luciano de Figueiredo Borges; Liliane Louedec; Yacine Boulaftali; Benoit Ho-Tin-Noé; Véronique Arocas; Marie-Christine Bouton; Jean-Baptiste Michel
Journal:  Front Physiol       Date:  2016-06-30       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.